Abivax S.A. (ABVX) Non-Current Deferred Tax Liability (2023 - 2026)

Abivax (ABVX) has reported Non-Current Deferred Tax Liability for 4 consecutive years, with $7.1 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Non-Current Deferred Tax Liability changed N/A year-over-year to $7.1 million; the TTM figure through Mar 2026 stood at $7.1 million (changed N/A YoY), while the FY2025 annual figure was $6.8 million, up 302.17% from the prior year.
• Non-Current Deferred Tax Liability came in at $7.1 million for Q1 2026 at Abivax, up from $6.8 million in the prior quarter.
• The five-year high for Non-Current Deferred Tax Liability was $7.1 million in Q1 2026, with the low at $477717.3 in Q4 2023.
• Average Non-Current Deferred Tax Liability over 4 years is $4.0 million, with a median of $4.2 million recorded in 2024.
• Across the five-year window, Non-Current Deferred Tax Liability soared 254.32% in 2024 and soared 302.17% in 2025, its largest moves.
• Year by year, Non-Current Deferred Tax Liability stood at $477717.3 in 2023, then soared by 254.32% to $1.7 million in 2024, then jumped by 302.17% to $6.8 million in 2025, then advanced by 4.5% to $7.1 million in 2026.
• According to Business Quant data, Non-Current Deferred Tax Liability over the past three periods registered $7.1 million, $6.8 million, and $1.7 million for Q1 2026, Q4 2025, and Q4 2024 respectively.